CV Sciences, Inc. Stock Price - CVSI

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Cv Sciences, Inc. (QB) CVSI OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.09 -4.13% 2.09 2.19 2.01 2.19 2.18 16:00:03
Bid Price Ask Price Spread Spread % News
2.05 2.09 0.04 1.91% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
609 576,924 $ 2.0791 $ 1,199,511 852,329 1.55 - 6.59
Last Trade Time Type Quantity Stock Price Currency
15:59:46 25 $ 2.09 USD

CV Sciences, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 207.53M 99.30M $ 10.00M - - 82.68M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.14M $ - 0.00% - -

more financials information »

CV Sciences, Inc. News

Loading Messages....

Latest CVSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CVSI Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.9752.21.781.9905626k0.1155.82%
1 Month2.522.711.552.10441M-0.43-17.06%
3 Months4.0054.161.552.7764890k-1.915-47.82%
6 Months5.595.841.553.5693736k-3.5-62.61%
1 Year5.756.591.554.5073989k-3.66-63.65%
3 Years0.65359.20.1362.98451M1.4365219.82%
5 Years2.959.20.12.6445831k-0.86-29.15%

CV Sciences, Inc. Description

CV Sciences, Inc. is a life science company that operates through two segments, specialty pharmaceuticals and consumer products. The Company focuses on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient and is engaged in the development, manufacturing, marketing and sale of consumer products containing plant-based CBD, which is refined into its own proprietary branded products. CV Sciences initial drug candidate (CVSI-007) is a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at $2 billion, growing to over $4 billion in the next 5-6 years.


Your Recent History
USOTC
CVSI
CV Science..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.